Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 24

1.

The Effects of Oxidation on the Antithrombotic Properties of Tea Lipids Against PAF, Thrombin, Collagen, and ADP.

Tsoupras A, Lordan R, Harrington J, Pienaar R, Devaney K, Heaney S, Koidis A, Zabetakis I.

Foods. 2020 Mar 26;9(4). pii: E385. doi: 10.3390/foods9040385.

2.

Forty Years Since the Structural Elucidation of Platelet-Activating Factor (PAF): Historical, Current, and Future Research Perspectives.

Lordan R, Tsoupras A, Zabetakis I, Demopoulos CA.

Molecules. 2019 Dec 3;24(23). pii: E4414. doi: 10.3390/molecules24234414. Review.

3.

Bioprospecting for Antithrombotic Polar Lipids from Salmon, Herring, and Boarfish By-Products.

Tsoupras A, O'Keeffe E, Lordan R, Redfern S, Zabetakis I.

Foods. 2019 Sep 15;8(9). pii: E416. doi: 10.3390/foods8090416.

4.

Total, Neutral, and Polar Lipids of Brewing Ingredients, By-Products and Beer: Evaluation of Antithrombotic Activities.

Lordan R, O'Keeffe E, Tsoupras A, Zabetakis I.

Foods. 2019 May 20;8(5). pii: E171. doi: 10.3390/foods8050171.

5.

The Potential Role of Dietary Platelet-Activating Factor Inhibitors in Cancer Prevention and Treatment.

Lordan R, Tsoupras A, Zabetakis I.

Adv Nutr. 2019 Jan 1;10(1):148-164. doi: 10.1093/advances/nmy090. Review.

6.

In Vitro Antithrombotic Properties of Salmon (Salmo salar) Phospholipids in a Novel Food-Grade Extract.

Tsoupras A, Lordan R, Shiels K, Saha SK, Nasopoulou C, Zabetakis I.

Mar Drugs. 2019 Jan 18;17(1). pii: E62. doi: 10.3390/md17010062.

7.

Platelet aggregometry assay for evaluating the effects of platelet agonists and antiplatelet compounds on platelet function in vitro.

Tsoupras A, Zabetakis I, Lordan R.

MethodsX. 2018 Dec 26;6:63-70. doi: 10.1016/j.mex.2018.12.012. eCollection 2019.

8.

Structural Elucidation of Irish Organic Farmed Salmon (Salmo salar) Polar Lipids with Antithrombotic Activities.

Tsoupras A, Lordan R, Demuru M, Shiels K, Saha SK, Nasopoulou C, Zabetakis I.

Mar Drugs. 2018 May 23;16(6). pii: E176. doi: 10.3390/md16060176.

9.

Inflammation, not Cholesterol, Is a Cause of Chronic Disease.

Tsoupras A, Lordan R, Zabetakis I.

Nutrients. 2018 May 12;10(5). pii: E604. doi: 10.3390/nu10050604. Review.

10.

Dairy Fats and Cardiovascular Disease: Do We Really Need to be Concerned?

Lordan R, Tsoupras A, Mitra B, Zabetakis I.

Foods. 2018 Mar 1;7(3). pii: E29. doi: 10.3390/foods7030029. Review.

11.

Phospholipids of Animal and Marine Origin: Structure, Function, and Anti-Inflammatory Properties.

Lordan R, Tsoupras A, Zabetakis I.

Molecules. 2017 Nov 14;22(11). pii: E1964. doi: 10.3390/molecules22111964. Review.

12.

In vivo effect of two first-line ART regimens on inflammatory mediators in male HIV patients.

Papakonstantinou VD, Chini M, Mangafas N, Stamatakis GM, Tsogas N, Tsoupras AB, Psarra K, Fragopoulou E, Antonopoulou S, Gargalianos P, Demopoulos CA, Lazanas MC.

Lipids Health Dis. 2014 May 29;13:90. doi: 10.1186/1476-511X-13-90.

13.

Paricalcitol effects on activities and metabolism of platelet activating factor and on inflammatory cytokines in hemodialysis patients.

Verouti SN, Tsoupras AB, Alevizopoulou F, Demopoulos CA, Iatrou C.

Int J Artif Organs. 2013 Feb;36(2):87-96. doi: 10.5301/ijao.5000187.

PMID:
23335378
14.

Synthesis, biochemical evaluation and molecular modeling studies of novel rhodium complexes with nanomolar activity against Platelet Activating Factor.

Tsoupras AB, Papakyriakou A, Demopoulos CA, Philippopoulos AI.

J Inorg Biochem. 2013 Mar;120:63-73. doi: 10.1016/j.jinorgbio.2012.12.004. Epub 2012 Dec 19.

PMID:
23318288
15.

Fish polar lipids retard atherosclerosis in rabbits by down-regulating PAF biosynthesis and up-regulating PAF catabolism.

Nasopoulou C, Tsoupras AB, Karantonis HC, Demopoulos CA, Zabetakis I.

Lipids Health Dis. 2011 Nov 16;10:213. doi: 10.1186/1476-511X-10-213.

16.

Effects of HAART on platelet-activating factor metabolism in naive HIV-infected patients I: study of the tenofovir-DF/emtricitabine/efavirenz HAART regimen.

Chini M, Tsoupras AB, Mangafas N, Tsogas N, Papakonstantinou VD, Fragopoulou E, Antonopoulou S, Gargalianos P, Demopoulos CA, Lazanas MC.

AIDS Res Hum Retroviruses. 2012 Aug;28(8):766-75. doi: 10.1089/AID.2011.0202. Epub 2011 Dec 22.

PMID:
22050695
17.

Platelet-activating factor and its basic metabolic enzymes in blood of naive HIV-infected patients.

Tsoupras AB, Chini M, Mangafas N, Tsogas N, Stamatakis G, Tsantila N, Fragopoulou E, Antonopoulou S, Gargalianos P, Demopoulos CA, Lazanas MC.

Angiology. 2012 Jul;63(5):343-52. doi: 10.1177/0003319711420608. Epub 2011 Sep 22.

PMID:
21948973
18.

In vitro anti-inflammatory and anti-coagulant effects of antibiotics towards Platelet Activating Factor and thrombin.

Tsoupras AB, Chini M, Tsogas N, Lioni A, Tsekes G, Demopoulos CA, Lazanas MC.

J Inflamm (Lond). 2011 Jul 7;8:17. doi: 10.1186/1476-9255-8-17.

19.

In vitro and in vivo effects of statins on platelet-activating factor and its metabolism.

Tsantila N, Tsoupras AB, Fragopoulou E, Antonopoulou S, Iatrou C, Demopoulos CA.

Angiology. 2011 Apr;62(3):209-18. doi: 10.1177/0003319710375089. Epub 2010 Aug 29.

PMID:
20805097
20.

Structurally diverse metal coordination compounds, bearing imidodiphosphinate and diphosphinoamine ligands, as potential inhibitors of the platelet activating factor.

Tsoupras AB, Roulia M, Ferentinos E, Stamatopoulos I, Demopoulos CA, Kyritsis P.

Bioinorg Chem Appl. 2010. pii: 731202. doi: 10.1155/2010/731202. Epub 2010 Jun 28.

Supplemental Content

Loading ...
Support Center